Preventive maintenance agreement for a BD biosciences flow cytometer (base + 4 option periods)

Ended Awarded Last action

Contract number
75F40119F80037
Awardee
Awarding agency
Obligated
$41,746

Award facts

Opportunity
Contract value 100% obligated
$41,746.23 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20993, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00005 $0
Exercise an Option P00004 $6,742
Other Administrative Action P00003 $0
Exercise an Option P00002 $11,668
Exercise an Option P00001 $11,668
Original award $11,668

About this award

The Food and Drug Administration awarded a $41,746.23 firm fixed-price delivery order to Becton, Dickinson and Company (BD Biosciences) on April 30, 2019, for preventive maintenance services on a BD flow cytometer instrument. The contract, which includes a base period and four option periods, extends through December 31, 2022, and will be performed at the FDA's facility in Silver Spring, Maryland. This delivery order was issued without a small business set-aside and represents BD's continued engagement with federal health agencies through its established capabilities in providing maintenance and technical support for advanced laboratory instrumentation.

BD Biosciences, a division of the global medical technology company Becton, Dickinson and Co, specializes in flow cytometry systems, cell imaging technologies, and laboratory equipment widely deployed across federal research and healthcare institutions. The company maintains an extensive contract portfolio with agencies including the National Institutes of Health, Department of Veterans Affairs, and Centers for Disease Control and Prevention. This preventive maintenance agreement supports the FDA's laboratory operations and reflects the agency's reliance on specialized biomedical equipment providers for sustained equipment functionality and research capability at its Silver Spring headquarters.

Quick answers

Who was awarded contract 75F40119F80037?

75F40119F80037 was awarded to Becton, Dickinson And Company by Food and Drug Administration (Department of Health and Human Services) on April 30, 2019.

How much is contract 75F40119F80037 worth?

The government has obligated $41,746 on 75F40119F80037.

Is contract 75F40119F80037 an order under another contract?

Yes. 75F40119F80037 is a delivery order under GS07F195DA, a federal supply schedule, on Scientific Equipment and Services (FSS-66).

Was contract 75F40119F80037 competed?

The extent of competition for 75F40119F80037 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award